Roche names Wafaa Mamilli as Chief Digital Technology Officer Ruchika Sharma31 Jan 2025 1:30 PM ISTBasel: Roche has announced that Wafaa Mamilli will join the company as Chief Digital Technology Officer (CDTO), reporting to Group CEO, Thomas...
Roche receives USFDA clearance with CLIA waiver for cobas liat sexually transmitted infection multiplex assay panels Ruchika Sharma26 Jan 2025 10:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement...
Roche gets USFDA clearance for highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma Ruchika Sharma14 Jan 2025 4:06 PM ISTBasel: Roche has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its...
Roche has no plans for job cuts and business is healthy: CEO Ruchika Sharma31 Dec 2024 4:48 PM ISTPharmaceutical giant Roche has no plans for workforce reductions and the company's business is healthy, CEO Thomas Schinecker was...
Pfizer, AstraZeneca and several other drugmakers in race to join weight loss drug market Ruchika Sharma23 Dec 2024 5:01 PM ISTPfizer, AstraZeneca, Amgen and several other drug developers aiming to join the weight-loss drug market, which is estimated to be worth about $150...
Roche Vabysmo prefilled syringe approved in EU for three retinal conditions that can cause blindness Ruchika Sharma15 Dec 2024 1:15 PM ISTBasel: Roche has announced that the European Medicines Agency has approved Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use...
USFDA accepts application for Roche Columvi combination for relapsed or refractory diffuse large B cell lymphoma Ruchika Sharma5 Dec 2024 11:30 AM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...
Roche to acquire Poseida Therapeutics for USD 1.5 billion Ruchika Sharma1 Dec 2024 10:45 AM ISTBasel: Roche has announced that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc., a public clinical-stage...
CDSCO Panel approves Roche Products' Polatuzumab Vedotin for Injection 30mg per vial for Diffuse large B-cell lymphoma Dr. Divya Colin30 Nov 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Roche's proposal...
Zydus barred from selling cancer drug Sigrima as Delhi HC restores injunction in favour of Roche Farhat Nasim16 Nov 2024 3:25 PM ISTNew Delhi: Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again reinstated an...
Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition MD Bureau24 Oct 2024 2:09 PM IST"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.
Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns MD Bureau19 Oct 2024 11:30 AM ISTThe deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly developing their own GLP 1 drugs.
